Publications
- Benefit of determining [-2]proPSA levels in the differential diagnosis of prostate cancer2014 | Faculty of Medicine in Pilsen
- Changes in serum levels of markers in early detection of prostate cancer (pilot study)2013 | Faculty of Medicine in Pilsen
- Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Chromogranin A in hormone independent prostate cancer2009 | Faculty of Medicine in Pilsen
- Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience2023 | Faculty of Medicine in Pilsen
- Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma2023 | Faculty of Medicine in Pilsen
- BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The potential of miR-499 plasmatic level as a biomarker of obstructive sleep apnea syndrome2021 | Faculty of Medicine in Pilsen
- Comparison of four routinely used vitamin D automated immunoassays2021 | Publication without faculty affiliation
- The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases2020 | Faculty of Medicine in Pilsen
Loading network view...